AM

Akhil Manojkumar Shah

Active Director Director DIN 02589855
DIN 02589855 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Feb 2010
Shareholding value •••• Premium profile

About Akhil Manojkumar Shah

Data last updated:

Akhil Manojkumar Shah is a Director at Lexine Technochem Private Limited (since 2010), Director at Gloria Interchem Private Limited (since 2016) and Director at Gloria Orgochem Private Limited (since 2024). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹51.60 Cr; the largest is Lexine Technochem Private Limited at ₹36.97 Cr (FY 2025). Earlier, Akhil Manojkumar Shah was a Director at Akhil Healthcare Private Limited (2017–2019) and Director at Blue Mark Health Care Private Limited (from 2011).

DIN 02589855
Primary Designation Director
Industry Pharma
First Appointment 19 Feb 2010
Oldest Company Age 19 yrs
Largest company Lexine Technochem Private Limited · ₹36.97 Cr (FY 2025)
Combined revenue ₹51.60 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lexine Technochem Private Limited U24230GJ2010PTC059643
Director19 Feb 20102010₹36.97 Cr (FY 2025)Active
Gloria Interchem Private Limited U24232GJ2016PTC086184
Director22 Feb 20162016₹10.50 Cr (FY 2025)Active
Gloria Orgochem Private Limited U20119GJ2021PTC123640
Director17 Jun 20242021₹4.13 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akhil Healthcare Private Limited U24231GJ2003PTC042667
Director01 Aug 20172003₹55.37 Cr (FY 2025)Active
Director15 Jul 20112007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Akhil Manojkumar Shah

Directorship timeline

Open interactive timeline →
Gloria Orgochem Private Limited
Lexine Technochem Private Limited
Gloria Interchem Private Limited
Blue Mark Health Care Private Limited
Premium access

Shareholding and investment profile for Akhil Manojkumar Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhil Manojkumar Shah

Akhil Manojkumar Shah currently holds 3 directorships: Lexine Technochem Private Limited (Director, since 19 Feb 2010, revenue ₹36.97 Cr (FY 2025)); Gloria Interchem Private Limited (Director, since 22 Feb 2016, revenue ₹10.50 Cr (FY 2025)); Gloria Orgochem Private Limited (Director, since 17 Jun 2024, revenue ₹4.13 Cr (FY 2024)).

Akhil Manojkumar Shah was first appointed on 19 Feb 2010 as Director at Lexine Technochem Private Limited. The most recent appointment on record is 17 Jun 2024 at Gloria Orgochem Private Limited.

The 3 current companies of Akhil Manojkumar Shah that report revenue have a combined latest revenue of ₹51.60 Cr: Lexine Technochem Private Limited ₹36.97 Cr (FY 2025); Gloria Interchem Private Limited ₹10.50 Cr (FY 2025); Gloria Orgochem Private Limited ₹4.13 Cr (FY 2024).

Akhil Manojkumar Shah held 2 earlier board appointments: Akhil Healthcare Private Limited (Director, 01 Aug 2017 to 25 Mar 2019); Blue Mark Health Care Private Limited (Director, from 15 Jul 2011).

The current boards of Akhil Manojkumar Shah's companies include Manoj Kanaiyalal Shah (Lexine Technochem Private Limited), Rudreshsinh Hanubha Vaghela (Gloria Orgochem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available